https://www.viromed.de/wp-content/uploads/2025/09/news17.webp
400
495
Viromed
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed2026-03-23 12:13:022026-03-23 12:13:02Viromed Medical AG erhält Förderzusage vom Bundesministerium für Forschung, Technologie und Raumfahrt für die Entwicklung von Kaltplasmatechnologie
https://www.viromed.de/wp-content/uploads/2025/09/news06.webp
400
495
Viromed
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed2026-01-07 17:13:032026-01-15 10:15:15Viromed AG: Strategic Update on Operational Focus and Value Creation
https://www.viromed.de/wp-content/uploads/2025/07/viromed-medical-news2.webp
400
495
Viromed
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed2025-07-29 15:28:032025-07-29 15:28:03Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority
https://www.viromed.de/wp-content/uploads/2025/05/plasmatherapie.webp
400
495
Viromed
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed2025-07-24 18:18:592025-07-27 19:48:57Viromed Medical AG enters into a distribution partnership with Tripart Titan GmbH & Co KG for the market launch of ViroCAP® and PulmoPlas® in Turkey
https://www.viromed.de/wp-content/uploads/2025/05/plasmatherapie.webp
400
495
Viromed
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed2025-06-23 10:14:082025-07-01 12:16:13Viromed Medical AG: Cold plasma technology shows potential to significantly reduce deaths in ventilated patients
https://www.viromed.de/wp-content/uploads/2025/06/business-shakehands.webp
800
990
Viromed
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed2025-06-06 18:35:042025-06-07 15:35:26Viromed Medical AG plans change in the Supervisory Board and Chairman of the Supervisory Board
https://www.viromed.de/wp-content/uploads/2025/05/plasmatherapie.webp
400
495
Viromed
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed2025-05-15 18:10:082025-06-03 09:13:46Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli)
https://www.viromed.de/wp-content/uploads/2025/04/shakehands2.webp
400
495
Viromed Redaktion
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed Redaktion2025-04-25 16:41:222025-05-15 16:42:05Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed’s entry into the European cosmetics market
https://www.viromed.de/wp-content/uploads/2025/04/investment2.webp
400
495
Viromed Redaktion
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed Redaktion2025-04-23 16:40:042025-05-15 16:40:30Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
0
0
Viromed Redaktion
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed Redaktion2025-04-10 16:38:412025-05-15 16:39:11Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use
https://www.viromed.de/wp-content/uploads/2025/04/pulmoplas-geraet.webp
400
495
Viromed Redaktion
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed Redaktion2025-04-10 16:35:082025-05-15 16:35:49Viromed Medical AG: UMECO Group acquires exclusive marketing rights in Asia for cold plasma medical devices ViroCAP® and PulmoPlas®
https://www.viromed.de/wp-content/uploads/2023/04/news-495x400-1.jpg
400
495
Viromed Redaktion
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed Redaktion2025-04-02 16:37:132025-05-15 16:37:42Viromed Medical AG to host Medical-Roundtable to discuss EUR 152.5 million distibution agreement with Asian UMECO Group on Wednesday, April 3rd, 2025 at 1:00PM CEST
https://www.viromed.de/wp-content/uploads/2025/03/intensivpatient.webp
400
495
Viromed Redaktion
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed Redaktion2025-03-14 16:32:342025-05-15 16:34:01Viromed Medical AG reports promising study results for PulmoPlas® in intensive care unit ventilator-associated pneumonia patients
https://www.viromed.de/wp-content/uploads/2023/09/wundbehandlung-thm.jpg
400
495
Viromed Redaktion
https://www.viromed.de/wp-content/uploads/2022/09/logo.png
Viromed Redaktion2023-10-06 16:47:182025-05-15 16:47:51Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds